within Pharmacolibrary.Drugs.ATC.B;

model B02BD07
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 4.725e-09,
    adminDuration  = 600,
    adminMass      = 35 / 1000000,
    adminCount     = 1,
    Vd             = 0.0437,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>CoagulationFactorXiii</td></tr><tr><td>ATC code:</td><td>B02BD07</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Coagulation factor XIII is a clotting factor essential for the final steps of the coagulation cascade by crosslinking fibrin. It is used as a replacement therapy in patients with factor XIII deficiency, a rare bleeding disorder. Factor XIII concentrates are approved for use today to treat and prevent bleeding in individuals with congenital factor XIII deficiency.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects (mean age ~29 years, both sexes) following intravenous administration of recombinant factor XIII.</p><h4>References</h4><ol><li><p>Dodds, MG, et al., &amp; Vicini, P (2005). Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys. <i>The AAPS journal</i> 7(3) E693â€“E703. DOI:<a href=\"https://doi.org/10.1208/aapsj070370\">10.1208/aapsj070370</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16353946/\">https://pubmed.ncbi.nlm.nih.gov/16353946</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>"
  ));
end B02BD07;
